Citadel Advisors’s Natural Health Trends NHTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.6K | Buy |
+10,600
| New | +$35.4K | ﹤0.01% | 12575 |
|
|
2025
Q1 | – | Sell |
-2,800
| Closed | -$12.9K | – | 15230 |
|
|
2024
Q4 | $12.9K | Sell |
2,800
-3,500
| -56% | -$19K | ﹤0.01% | 13477 |
|
|
2024
Q3 | $37.5K | Buy |
6,300
+5,400
| +600% | +$37K | ﹤0.01% | 12217 |
|
|
2024
Q2 | $6.39K | Sell |
900
-1,500
| -63% | -$10.3K | ﹤0.01% | 13332 |
|
|
2024
Q1 | $16.1K | Sell |
2,400
-200
| -8% | -$1.25K | ﹤0.01% | 13154 |
|
|
2023
Q4 | $15.2K | Sell |
2,600
-200
| -7% | -$1.1K | ﹤0.01% | 12847 |
|
|
2023
Q3 | $15K | Buy |
+2,800
| New | +$15.2K | ﹤0.01% | 12845 |
|
|
2023
Q1 | – | Sell |
-2,100
| Closed | -$7.14K | – | 15218 |
|
|
2022
Q4 | $7.14K | Buy |
+2,100
| New | +$8K | ﹤0.01% | 13845 |
|
|
2021
Q4 | – | Sell |
-10,800
| Closed | -$77K | – | 14425 |
|
|
2021
Q3 | $77K | Buy |
+10,800
| New | +$75.3K | ﹤0.01% | 13100 |
|
|
2020
Q3 | – | Sell |
-15,100
| Closed | -$86K | – | 10515 |
|
|
2020
Q2 | $86K | Sell |
15,100
-900
| -6% | -$4.66K | ﹤0.01% | 9076 |
|
|
2020
Q1 | $53K | Sell |
16,000
-200
| -1% | -$810 | ﹤0.01% | 9005 |
|
|
2019
Q4 | $87K | Sell |
16,200
-4,900
| -23% | -$31.3K | ﹤0.01% | 8592 |
|
|
2019
Q3 | $149K | Buy |
21,100
+7,400
| +54% | +$54.3K | ﹤0.01% | 8305 |
|
|
2019
Q2 | $110K | Buy |
+13,700
| New | +$143K | ﹤0.01% | 8507 |
|
|
2019
Q1 | – | Sell |
-13,300
| Closed | -$246K | – | 9669 |
|
|
2018
Q4 | $246K | Sell |
13,300
-25,500
| -66% | -$561K | ﹤0.01% | 7575 |
|
|
2018
Q3 | $903K | Buy |
38,800
+13,200
| +52% | +$323K | ﹤0.01% | 5723 |
|
|
2018
Q2 | $641K | Buy |
+25,600
| New | +$536K | ﹤0.01% | 5973 |
|
|
2018
Q1 | – | Sell |
-17,400
| Closed | -$264K | – | 8606 |
|
|
2017
Q4 | $264K | Buy |
+17,400
| New | +$328K | ﹤0.01% | 6665 |
|
|
2017
Q2 | – | Sell |
-15,800
| Closed | -$457K | – | 7863 |
|
|
2017
Q1 | $457K | Sell |
15,800
-16,800
| -52% | -$452K | ﹤0.01% | 5179 |
|
|
2016
Q4 | $810K | Sell |
32,600
-6,500
| -17% | -$164K | ﹤0.01% | 4165 |
|
|
2016
Q3 | $1.1M | Sell |
39,100
-3,100
| -7% | -$96.1K | ﹤0.01% | 3718 |
|
|
2016
Q2 | $1.19M | Sell |
42,200
-10,800
| -20% | -$353K | ﹤0.01% | 3362 |
|
|
2016
Q1 | $1.76M | Buy |
53,000
+7,000
| +15% | +$190K | ﹤0.01% | 2788 |
|
|
2015
Q4 | $1.54M | Buy |
46,000
+41,800
| +995% | +$1.84M | ﹤0.01% | 3039 |
|
|
2015
Q3 | $137K | Buy |
4,200
+2,000
| +91% | +$60.6K | ﹤0.01% | 6613 |
|
|
2015
Q2 | $91K | Buy |
+2,200
| New | +$65.2K | ﹤0.01% | 7170 |
|
Other funds holding NHTC
VCM
VFT
BCM
Citadel Advisors's NHTC Position: Q1 2026 in Review
Citadel Advisors reduced its Natural Health Trends (NHTC) stake by 45% in Q1 2026, selling an estimated $91.8K and leaving 33,414 shares worth $93.2K. The position accounts for ﹤0.01% of the portfolio, ranked #12073.
Citadel Advisors first reported a position in NHTC in Q2 2015 and has held it in 21 quarters since. The position peaked at $704K in Q1 2019. 23 funds tracked by Wall St. Rank hold NHTC as of Q1 2026.
- Citadel Advisors held 33,414 shares of Natural Health Trends worth $93.2K as of Q1 2026.
- Citadel Advisors sold 27,457 Natural Health Trends shares in Q1 2026, an estimated $91.8K.
- Natural Health Trends made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12073 holding.
- Citadel Advisors first reported a position in Natural Health Trends in Q2 2015 and has held it in 21 quarters since.
- Citadel Advisors's Natural Health Trends position peaked at $704K in Q1 2019.
- 23 funds tracked by Wall St. Rank held Natural Health Trends as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.